Citation 79905

KATO,T: TOMITA,M: TAKIGAWA,M: IWASAKI,H: HIRUKAWA,T: YAMAHARA,J:. (1994). INHIBITORY EFFECTS AND ACTIVE CONSTITUENTS OF ALISMA RHIZOMES ON VASCULAR CONTRACTION INDUCED BY HIGH CONCENTRATION OF KCL.. 67(5)

Citation Details

Title	INHIBITORY EFFECTS AND ACTIVE CONSTITUENTS OF ALISMA RHIZOMES ON VASCULAR CONTRACTION INDUCED BY HIGH CONCENTRATION OF KCL.
Authors	KATO,T: TOMITA,M: TAKIGAWA,M: IWASAKI,H: HIRUKAWA,T: YAMAHARA,J:
Year	1994
Volume	67
Issue	5

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Alisma plantago-aquatica (ALISMATACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ALISOL C MONOACETATE	None
2	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL C MONOACETATE	WEAK ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ALISOL C	None
4	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL C	INACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ALSIMA TRITERPENE 3	None
6	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALSIMA TRITERPENE 3	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ALISMA TRITERPENE 4	None
8	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMA TRITERPENE 4	ACTIVE
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ALISMA TRITERPENE 5	None
10	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMA TRITERPENE 5	WEAK ACTIVITY
11	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ALISOL B	None
12	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL B	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	ALISMOXIDE	None
14	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOXIDE	ACTIVE

Show SPARQL Queries (1)